Drug delivery in leptomeningeal disease: Navigating barriers and beyond

Drug delivery in leptomeningeal disease: Navigating barriers and beyond

Leptomeningeal disease (LMD) refers to the infiltration of cancer cells into the leptomeningeal compartment. Leptomeninges are the two membranous layers, called the arachnoid membrane and pia mater. The diffuse nature of LMD poses a challenge to its effective diagnosis and successful management. Fur...

Full description

Saved in:

Bibliographic Details
Main Authors:	Numair Arshad, Nupur Biswas, Jaya Gill, Santosh Kesari, Shashaanka Ashili
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2024-12-01
Series:	Drug Delivery
Subjects:	Leptomeningeal disease neoplastic meningitis leptomeninges CNS metastasis Intrathecal chemotherapy Leptomeningeal metastasis
Online Access:	https://www.tandfonline.com/doi/10.1080/10717544.2024.2375521
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Beyond the brain: exploring the impact of animal models of leptomeningeal disease from solid tumors
by: Jillyn R. Turunen, et al.
Published: (2025-05-01)

Clinical characteristics and prognostic factors in patients with breast cancer and leptomeningeal metastases from a large registry of BMBC
by: Elena Laakmann, et al.
Published: (2025-06-01)

Intrathecal administration of PD-1 inhibitor combined with pemetrexed for leptomeningeal metastases from breast cancer: a case report
by: Yushan Huang, et al.
Published: (2025-04-01)

Diffuse Leptomeningeal Glioneuronal Tumor in an Adult: A Diagnostic Challenge
by: Mukesh Kumar Bhaskar, et al.
Published: (2022-01-01)

Primary diffuse leptomeningeal melanomatosis in a child with a clinical presentation mimicking meningitis: case report and review of literature
by: P. V. Sudharsan, et al.
Published: (2025-05-01)

Rare leptomeningeal recurrence of mucinous ovarian carcinoma
by: Gabrielle LeBlanc, et al.
Published: (2025-06-01)

High-dose third-generation EGFR-TKIs combined with intrathecal pemetrexed in advanced EGFR-mutant NSCLC with leptomeningeal metastases following EGFR-TKI therapy
by: Shugui Wu, et al.
Published: (2025-05-01)

Challenges and strategies toward oncolytic virotherapy for leptomeningeal metastasis
by: Jia-Li Zhao, et al.
Published: (2024-11-01)

Exploratory profiling of metabolites in cerebrospinal fluid using a commercially available targeted LC-MS based metabolomics kit to discriminate leptomeningeal metastasis
by: Soojin Jang, et al.
Published: (2025-01-01)

Case report: Leptomeningeal metastasis of advanced nasopharyngeal carcinoma treated with chemoimmunotherapy
by: Mengting Shi, et al.
Published: (2023-12-01)

Hereditary leptomeningeal transthyretin amyloidosis with heterozygous TTR mutation: a case report and literature review
by: Hong-Tao Chen, et al.
Published: (2025-05-01)

Cerebrospinal fluid approach on neuro-oncology
by: Helio Rodrigues Gomes
Published: (2013-09-01)

Intrathecal pemetrexed chemotherapy combined with systemic therapy in patients with non-small cell lung cancer and leptomeningeal metastases: a retrospective study
by: Wenjuan Zhong, et al.
Published: (2025-04-01)

Leptomeningeal metastasis in triple-negative breast cancer: a retrospective study
by: Yun-Yi Wang, et al.
Published: (2025-08-01)

A review on intrathecal administration of medications for leptomeningeal metastases in solid tumors
by: Xuemei Wang, et al.
Published: (2025-02-01)

Intrathecal trastuzumab for leptomeningeal carcinomatosis in patients with human epidermal growth factor receptor 2 positive breast cancer
by: Seema Gulia, et al.
Published: (2016-01-01)

Leptomeningeal metastasis with sturge-weber syndrome-like gyriform calcification on imaging: a case report
by: Yang Liu, et al.
Published: (2025-07-01)

Diagnosing primary malignancy in leptomeningeal carcinomatosis by using CSF cytology and immunohistochemistry: A case report
by: Navaneeth Reddy Hasthavaram, et al.
Published: (2020-01-01)

Population-Based Real-World Outcomes of Post-Operative Adjuvant Brain Cavity Radiotherapy Versus Observation
by: Zhang Hao (Jim) Li, et al.
Published: (2025-06-01)

HER2+ esophageal carcinoma leptomeningeal metastases treated with intrathecal trastuzumab regimen
by: Scott A Wu, et al.
Published: (2023-09-01)

Intrathecal Trastuzumab as a Novel Simplified Therapeutic Strategy for Isolated Metastases in the Leptomeninges in HER2-Positive Breast Cancer: A Case Report and Review of Literature
by: Lokesh K. Nagendrappa, et al.

Gut microbiota and metabolite features in NSCLC nude mouse models of subcutaneous tumor and leptomeningeal metastasis: a microbiome-metabolome combined analysis
by: Yang Du, et al.
Published: (2025-06-01)

Combination of antiangiogenic and systemic therapy in advanced non-small cell lung cancer: before and after progression to leptomeningeal metastasis
by: Xiao-dan Zhu, et al.
Published: (2025-04-01)

Chinese Expert Consensus on Leptomeningeal Metastases of Lung Cancer
by: Gen Lin, et al.
Published: (2025-06-01)

Intrathecal pemetrexed efficacy and cerebrospinal fluid tumor marker response in refractory leptomeningeal metastasis of non-small-cell lung cancer: a single-arm phase II trial
by: Qingsheng Xu, et al.
Published: (2025-05-01)

Integration of continuous lumbar drainage and third-generation EGFR-TKI in managing leptomeningeal metastasis-induced life-threatening intracranial hypertension: a case report
by: Lei Wang, et al.
Published: (2025-05-01)

Survival outcomes among patients with breast cancer and leptomeningeal disease
by: Badr Id Said, et al.
Published: (2025-07-01)

Evaluation of CE-MATRIX-Enhanced FLAIR imaging in the detection of leptomeningeal metastasis
by: Junhui Yuan, et al.
Published: (2025-04-01)

The bloomy rind sign: A key imaging clue in early leptomeningeal carcinomatosis from lung cancer—A case report
by: Karim Haddar, et al.
Published: (2025-08-01)

Treatment of Leptomeningeal Disease with Tepotinib in a Patient with Lung Adenocarcinoma Harboring MET Exon 14 Skipping Mutation Presenting with Extensive Metastasis Involving Duodenum
by: Jacquelyn Shugarts, et al.
Published: (2025-06-01)

The efficacy and safety of intrathecal pemetrexed for leptomeningeal metastasis from non-small cell lung cancer: a single-arm meta-analysis of Chinese patients
by: Yushi Zhao, et al.
Published: (2025-06-01)

Correction: The efficacy and safety of intrathecal pemetrexed for leptomeningeal metastasis from non-small cell lung cancer: a single-arm meta-analysis of Chinese patients
by: Yushi Zhao, et al.
Published: (2025-07-01)

The presentation and diagnostic utility of xanthochromia in current practice
by: Marzia Maliha, et al.
Published: (2024-12-01)

Leptomeningeal cyst in an adult following childhood trauma: a case report
by: Bereket Girum Beyene, MD, et al.
Published: (2025-05-01)

A rare case of multifocal craniospinal leptomeningeal melanocytoma: A case report and scoping review
by: Daniel Lewis, et al.
Published: (2024-01-01)

A rare case of vision loss caused by leptomeningeal metastasis of lung adenocarcinoma: a case report and literature review
by: Zhihua Li, et al.
Published: (2025-02-01)

Clinical Insights into Neurosyphilis Patients with Leptomeningeal Enhancement of Spinal Cord
by: Zhang W, et al.
Published: (2024-12-01)

An Uncommon Presentation of Leptomeningeal Metastases in Breast Carcinoma Detected by F-18 FDG PET/CT
by: Gavini Surya, et al.
Published: (2022-09-01)

Stroke associated with microvascular tumoral infiltration in a patient with metastatic breast cancer
by: Joshua Mangerel, MD, et al.
Published: (2025-03-01)

Cognitive and Behavioral Deficits in Neurocutaneous Syndromes
by: J Gordon Millichap
Published: (2005-11-01)